应用深度学习方法人工智能用于肾下型腹主动脉瘤腔内修复术后随访
本研究评估基于人工智能的软件PRAEVAorta 2在腹主动脉瘤腔内修复(EVAR)术后随访中评估主动脉形态变化、检测内漏及关联不良事件的能力。纳入2017年1月至2020年3月在一家三级医院接受EVAR且有至少2次随访CTA的56例患者,中位影像随访27个月。软件检测内漏的敏感度为89.47%、特异度为91.25%、阳性预测值为90.67%、阴性预测值为90.12%;EVAR相关不良事件与总体体积变化相关(AUC 0.7806),优于最大直径(AUC 0.7277)。
要点
- PRAEVAorta检测内漏的敏感度89.47%、特异度91.25%、阳性预测值90.67%、阴性预测值90.12%。
- EVAR相关不良事件与总体体积变化的AUC为0.7806,最大直径为0.7277。
- 随访期间最大动脉瘤直径和体积无显著变化,但血栓体积下降13.47%(p=0.0216)。
核心结论
- 基于人工智能的软件PRAEVAorta能够对EVAR术后主动脉重塑进行详细解剖学表征,并显示出在随访中自动检测内漏的潜在价值。
- 主动脉瘤体积与EVAR相关不良事件及内漏的关联比最大直径更稳健。
研究设计与样本
- 单中心研究,纳入2017年1月至2020年3月在一家三级医院接受EVAR且有至少2次随访CTA的患者56例,中位影像随访27个月(IQR 20-40)。
- 使用PRAEVAorta 2(Nurea)软件分析,以人类专家提供的基准真值进行比较,计算敏感度、特异度、阴性预测值和阳性预测值。
- EVAR相关不良事件定义为动脉瘤相关死亡、破裂、内漏、肢体闭塞和EVAR相关再干预。
主要发现
- 最大动脉瘤直径从55.62 mm(IQR 52.33-59.25)变为54.34 mm(IQR 46.13-59.47),无显著差异(p=0.2162)。
- 动脉瘤体积从130.4 cm3(IQR 113.8-171.7)变为125.4 cm3(IQR 96.3-169.1),无显著差异(p=0.1131)。
- 血栓体积下降13.47%(p=0.0216)。
- PRAEVAorta检测内漏的敏感度为89.47%(95%CI 80.58-94.57),特异度为91.25%(95%CI 83.02-95.70),阳性预测值为90.67%(95%CI 81.97-95.41),阴性预测值为90.12%(95%CI 81.70-94.91)。
- EVAR相关不良事件与总体体积变化的AUC为0.7806,最大直径为0.7277;内漏的AUC分别为0.7086和0.6711。
临床怎么用
- 作者指出,将PRAEVAorta人工智能软件整合到临床实践中可能为EVAR术后监测带来变革,提供内漏的精确快速检测和全面解剖评估。
- 作者认为,该创新减少了对人工测量的依赖,可能减少解读错误并缩短评估时间,最终可能优化患者护理、实现更及时干预并改善EVAR结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Endoleaks represent one of the main complications after endovascular aortic repair (EVAR) and can lead to increased re-intervention rates and secondary rupture. Serial lifelong surveillance is required and traditionally involves cross-sectional imaging with manual axial measurements. Artificial intelligence (AI)-based imaging analysis has been developed and may provide a more precise and faster assessment. This study aims to evaluate the ability of an AI-based software to assess post-EVAR morphological changes over time, detect endoleaks, and associate them with EVAR-related adverse events. METHODS: Patients who underwent EVAR at a tertiary hospital from January 2017 to March 2020 with at least 2 follow-up computed tomography angiography (CTA) were analyzed using PRAEVAorta 2 (Nurea). The software was compared to the ground truth provided by human experts using Sensitivity (Se), Specificity (Sp), Negative Predictive Value (NPV), and Positive Predictive Value (PPV). Endovascular aortic repair-related adverse events were defined as aneurysm-related death, rupture, endoleak, limb occlusion, and EVAR-related re-interventions. RESULTS: Fifty-six patients were included with a median imaging follow-up of 27 months (interquartile range [IQR]: 20-40). There were no significant differences overtime in the evolution of maximum aneurysm diameters (55.62 mm [IQR: 52.33-59.25] vs 54.34 mm [IQR: 46.13-59.47]; p=0.2162) or volumes (130.4 cm3 [IQR: 113.8-171.7] vs 125.4 cm3 [IQR: 96.3-169.1]; p=0.1131) despite a -13.47% decrease in the volume of thrombus (p=0.0216). PRAEVAorta achieved a Se of 89.47% (95% confidence interval [CI]: 80.58 to 94.57), a Sp of 91.25% (95% CI: 83.02 to 95.70), a PPV of 90.67% (95% CI: 81.97 to 95.41), and an NPV of 90.12% (95% CI: 81.70 to 94.91) in detecting endoleaks. Endovascular aortic repair-related adverse events were associated with global volume modifications with an area under the curve (AUC) of 0.7806 vs 0.7277 for maximum diameter. The same trend was observed for endoleaks (AUC of 0.7086 vs 0.6711). CONCLUSIONS: The AI-based software PRAEVAorta enabled a detailed anatomic characterization of aortic remodeling post-EVAR and showed its potential interest for automatic detection of endoleaks during follow-up. The association of aortic aneurysmal volume with EVAR-related adverse events and endoleaks was more robust compared with maximum diameter. CLINICAL IMPACT: The integration of PRAEVAorta AI software into clinical practice promises a transformative shift in post-EVAR surveillance. By offering precise and rapid detection of endoleaks and comprehensive anatomic assessments, clinicians can expect enhanced diagnostic accuracy and streamlined patient management. This innovation reduces reliance on manual measurements, potentially reducing interpretation errors and shortening evaluation times. Ultimately, PRAEVAorta's capabilities hold the potential to optimize patient care, leading to more timely interventions and improved outcomes in endovascular aortic repair.
引用
- Coatsaliou Q, Lareyre F, Raffort J, et al. Use of Artificial Intelligence With Deep Learning Approaches for the Follow-up of Infrarenal Endovascular Aortic Repair. J Endovasc Ther. 2024. PMID: 38721876. doi:10.1177/15266028241252097
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。